ICIs may induce autoimmune phenomena

An interesting case report on 59-year-old woman. Patient get a malignant melanoma and receiving checkpoint inhibition therapy with pembrolizumab. The patient developed arthritis of the right knee at week 30.

doi: 10.1097/MD.0000000000019439

First released 25 jan 2020